21:15 22/07/2014 Eye-Catching Stocks – Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), EXCO ...
Eye-Catching Stocks – Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), EXCO ...
Techsonian (press release) - 7 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) decreased -0.58% at the price of $4.85 recently on a traded volume of 1.84 million shares, in comparison to 5.63 million shares of average trading volume.

19:11 22/07/2014 Morning Alert-Arena Pharmaceuticals, Inc. (Nasdaq :ARNA) ,Ariad ...
Morning Alert-Arena Pharmaceuticals, Inc. (Nasdaq :ARNA) ,Ariad ...
Techsonian (press release) - 9 hours ago
Las Vegas, NV - July 22, 2014 - (TechSonian) –Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) declared that it will report its second quarter 2014 financial results on Wednesday, August 6, 2014, before the market opens.

14:07 22/07/2014 News Recap: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Geron Corporation ...
News Recap: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Geron Corporation ...
Market News Call - 14 hours ago
Lakeway, NY - (MARKET NEWS CALL) - 7/22/2014— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.

14:06 22/07/2014 Considerable News in Focus- Euro Tech Holdings (NASDAQ:CLWT), Arena ...
Considerable News in Focus- Euro Tech Holdings (NASDAQ:CLWT), Arena ...
eMarketsDaily - 14 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) [Trend Analysis] reported that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has signed into an exclusive marketing and supply agreement for BELVIQ (lorcaserin HCl) with Teva Pharmaceutical ...

13:56 22/07/2014 Stocks in News – VIVUS Inc. (NASDAQ:VVUS), Arena Pharmaceuticals ...
Stocks in News – VIVUS Inc. (NASDAQ:VVUS), Arena Pharmaceuticals ...
Crazy Joys - 14 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s wholly owned subsidiary Arena Pharmaceuticals GmbH has undertaken a marketing and supply deal for BELVIQ® with Abic Marketing Limited, the local Israel-based subsidiary of Teva Pharmaceutical ...

12:03 22/07/2014 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sells Marketing And Distribution ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sells Marketing And Distribution ...
USTrade Voice - 16 hours ago
Dallas, Texas 07/22/2014 (ustradevoice) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s wholly owned subsidiary Arena Pharmaceuticals GmbH has undertaken a marketing and supply deal for BELVIQ® with Abic Marketing Limited, the local Israel-based ...
Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ ... - Wall Street Journal
Arena Pharmaceuticals to Market and Supply BELVIQ in Israel - Pharmaceutical Processing

20:30 16/07/2014 Arena Pharmaceuticals Pain Candidate Gets New U.S. Patent
Arena Pharmaceuticals Pain Candidate Gets New U.S. Patent
Zacks.com - Jul 16, 2014
The U.S. Patent and Trademark Office issued a new patent to Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) for its pain candidate APD371 (U.
Arena Gives Pipeline Exposure - Is The Company Partner Shopping? (ARNA) - Seeking Alpha

22:00 15/07/2014 Arena Pharmaceuticals Inc. Still Down After CEO's Sale
Arena Pharmaceuticals Inc. Still Down After CEO's Sale
Motley Fool - Jul 15, 2014
"Week-over-week prescriptions are increasing. We're very excited about that. And we expect those prescriptions to continue to increase as, yet a larger salesforce, goes into the field in the next few weeks.

18:48 07/07/2014 Why Arena Pharmaceuticals (ARNA) Stock Is Dropping Today
Why Arena Pharmaceuticals (ARNA) Stock Is Dropping Today
TheStreet.com - Jul 7, 2014
NEW YORK (TheStreet) -- Arena Pharmaceuticals (ARNA_) shares are plummeting, down -8.1% to $5.37, on Monday after CEO Jack Lief sold 223,525 shares of the company at an average price $5.85 for a total transaction of $1,307,621.25, according to an ...
Arena Stock Takes A Tumble – CEO Sells Shares, Investor Confidence Falls - Bidness Etc
Arena chief's stock sale invites criticism (ARNA) - Seeking Alpha